Creative Biolabs provides a rapid, reliable, and highly customizable platform for the in vivo validation of T-cell-focused immunotherapies. We deliver critical efficacy, safety, and mechanism of action (MOA) data, focusing on T-cell function and tumor inhibition. Clients gain accelerated pre-clinical decision-making capabilities, an extended therapeutic observation window thanks to our GVHD mitigation protocols, and sophisticated immunological reports, ensuring their research assets move forward with high confidence.
Metabolism information is key to understanding drug safety and efficacy. Among them, metabolite identification runs through the entire process of drug development.
Fig.1 Metabolic processes. 1
Initiate a project consultation to evaluate our service capabilities.
Identification Service
The traditional metabolite identification process requires long-term LC-MS analysis and a lot of manual data interpretation. Creative Biolabs provides a rapid, high-throughput method for identifying metabolic soft spots to meet throughput requirements in the early stages of drug discovery.
Learn More →Creative Biolabs offers in vitro cross-species comparisons, which use in vitro models to perform experiments to assess similarities and differences in biological responses between different species, such as drug metabolism, toxicity, or efficacy.
Learn More →Identification Type
| In vitro incubation metabolite identification | Metabolite identification in vivo | Identification of reactive metabolites |
|---|---|---|
| Liver microsomes, S9, primary hepatocytes, lysosomes, tumor cells, whole blood, plasma, etc. | Plasma, urine, bile, feces, tissues, and organs, etc. | GSH trapping |
| Key Features | Unique Advantages |
|---|---|
| Superior Resolution | We utilize advanced separation (HILIC) and mass spectrometry to resolve and characterize complex isomeric metabolites that are often missed by conventional approaches. |
| Documentation Focus | Our reports are built around stringent structural criteria, providing the necessary cross-species comparison in plasma and definitive structural identification to satisfy stringent documentation requirements from the outset. |
| Seamless Quantification | We directly link Level 1 structural ID to the development of robust LC-MS/MS quantification methods, ensuring zero data gap between qualitative and quantitative studies. |
To leverage the Creative Biolabs' competitive advantage, please submit a formal request for quotation.
Choosing the right metabolite identification method depends on several factors, including the nature of the metabolite, the complexity of the sample matrix, the sensitivity required, and the available resources. If you have questions about this, you can contact our technicians directly for the best advice.
Soft spot identification involves a systematic analysis of metabolic pathways, cellular processes, or biological systems to identify points of vulnerability, sensitivity, or importance for physiological or pathological outcomes. This can be achieved through a combination of experimental techniques, computational modeling, and data analysis approaches.
Evaluates metabolic heterogeneity within the tumor microenvironment at the single-cell level, providing high-resolution profiling to identify mechanisms of immune evasion and therapeutic targets.
Learn More →Provides precise quantification of drug candidates and metabolites in diverse biological matrices using LC-MS/MS and ligand-binding assays to support pharmacokinetic and pharmacodynamic evaluations.
Learn More →With rich experience in in vivo /in vitro screening and evaluation, relying on advanced technology and instruments, the Creative Biolabs expert team has developed a research platform for the analysis and identification of DMPK metabolites, and formulated a series of perfect countermeasures for the difficulties in the experimental process. Please feel free to contact us for more information about our services.